Tag: Sintez

Sistema Acquired Stakes in Sintez and Biocom

Sistema PJSFC, a publicly-traded diversified Russian holding company, announces that it has completed the acquisition, together with a financial partner, of a 46.5% equity stake in Sintez Kurganskoe M...

Sintez Could Put 99.98% of 2018 Net Income in Development

The board of directors of the Kurgan-based pharmaceutical company Sintez has urged shareholders ahead of an annual shareholder meeting scheduled for June 28, to keep nearly all of the 2018 net income ...

Kurgan-based Sintez is the leading manufacturer of antibiotics in Russia

sintez kurgan
In 2017, Sintez pharmaceutical plant once again became a leader in the Russian market of antibiotics by producing more than 32 million packages of antibacterial agents, or 23% of the total antibiotics manufactured in Russia.

Kurgan-based Sintez will invest 200 million rubles in labeling equipment

sintez kurgan
By 2020, JSC Joint-Stock Kurgan Company of Medicinal Products and Devices Sintez will invest more than 200 million rubles in the drug labeling equipment.

Nacimbio presents its key projects and new R&D

Nacimbio, a pharmaceutical holding company of Rostec Corporation, takes part in PharmMedProm-2017 exhibition held during the Russian Health Care Week

Kurgan-based Sintez launches 4 new plastic blood bags to the market

blood bag
Sintez has received the registration certificates for four types of plastic bags for the blood and its components

Kurgan-based Sintez demonstrates strong financial results

sintez kurgan
JSC Joint-Stock Kurgan Company of Medicines and Products Sintez released its financial statements for 6 months

Nacimbio produce more than 70% of required immunization medicines

National Immunobiological Company presented its immunobiological products at all-Russian forum and exhibition "State Order – For Fair Procurement". Nacimbio plants produce more than 70% of the volume ...

Kurgan-based Sintez increased its net profit by 2.1 times in 2016

JSC Joint-Stock Company Kurgan medicines and products "Sintez", a part of National Immunobiological Company (Rostec Corporation), increased its net profit under RAS by 2.1 times in 2016 compared to 20...